HomeRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Previous close
$7.35
Day range
$7.26 - $7.84
Year range
$4.97 - $15.74
Market cap
2.20B USD
Avg Volume
5.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 14.42M | 30.86% |
Operating expense | 31.83M | 12.52% |
Net income | -97.54M | -27.13% |
Net profit margin | -676.56 | 2.85% |
Earnings per share | -0.40 | -5.26% |
EBITDA | -91.58M | -20.22% |
Effective tax rate | 0.53% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 474.34M | 16.87% |
Total assets | 775.86M | 16.37% |
Total liabilities | 191.41M | -3.20% |
Total equity | 584.45M | — |
Shares outstanding | 280.97M | — |
Price to book | 3.53 | — |
Return on assets | -37.69% | — |
Return on capital | -44.63% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -97.54M | -27.13% |
Cash from operations | -82.22M | -21.87% |
Cash from investing | -4.18M | -103.70% |
Cash from financing | 263.12M | 6,848.03% |
Net change in cash | 176.60M | 369.41% |
Free cash flow | -41.52M | -78.35% |
About
Founded
2013
Headquarters
Website
Employees
500